Immunostimulatory DNA for asthma: Better than eating dirt

American Journal of Respiratory Cell and Molecular Biology

Volumn 28, Issue 6, 2003, Pages 645-647

  Silverman, Eric S ^a   Drazen, Jeffrey M ^b  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYTOSINE; DNA; GLUCOCORTICOID; IMMUNOSTIMULATING AGENT;

ANTIGEN PRESENTING CELL; ASTHMA; DNA FLANKING REGION; DNA SEQUENCE; EATING; GOBLET CELL; HELPER CELL; HOMEOSTASIS; HYGIENE; HYPOTHESIS; IMMUNE SYSTEM; IMMUNITY; IMMUNOSTIMULATION; IN VIVO STUDY; MACROPHAGE; METAPLASIA; NONHUMAN; PREDICTION; PREVENTION; REVIEW;

ANIMALS; ASTHMA; CPG ISLANDS; DISEASE MODELS, ANIMAL; DNA; HUMANS; IMMUNITY, NATURAL; IMMUNOTHERAPY; OLIGODEOXYRIBONUCLEOTIDES; PICA; TH1 CELLS; TH2 CELLS;

EID: 0038313021     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/rcmb.F268     Document Type: Review

References (31)

1. Janeway, C. A., Jr., and R. Medzhitov. 2002. Innate immune recognition. Annu. Rev. Immunol. 20:197-21.6.
2. Weiss, S. T. 2002. Eat dirt-the hygiene hypothesis and allergic diseases. N. Engl. J. Med. 347:930-931.
3. Yazdanbakhsh, M., P. G. Kremsner, and R. van Ree. 2002. Allergy, parasites, and the hygiene hypothesis. Science 296:490-494.
4. Wills-Karp, M., J. Santeliz, and C. L. Karp. 2001. The germless theory of allergic disease: revisiting the hygiene hypothesis. Nat. Rev. Immunol. 1:69-75.
5. Ikeda, R. K., J. Nayar, J. Y. Cho, M. Miller, M. Rodriguez, E. Raz, and D. H. Broide. 2003. Resolution of airway inflammation following ovalbumin inhalation: comparison of ISS DNA and corticosteroids. Am. J. Respir. Cell Mol. Biol. 28:655-663.
6. Tokunaga, T., T. Yamamoto, and S. Yamamoto. 1999. How BCG led to the discovery of immunostimulatory DNA. Jpn. J. Infect. Dis. 52:1-11.
7. Krieg, A. M. 2002. CpG motifs in bacterial DNA and their immune effects. Annu. Rev. Immunol. 20:709-760.
8. Horner, A. A., J. H. Van Uden, J. M. Zubeldia, D. Broide, and E. Raz. 2001. DNA-based immunotherapeutics for the treatment of allergic disease. Immunol. Rev. 179:102-118.
9. Krieg, A. M., A. K. Yi, S. Matson, T. J. Waldschmidt, G. A. Bishop, R. Teasdale, G. A. Koretzky, and D. M. Klinman. 1995. CpG motifs in bacterial DNA trigger direct B-ceil activation. Nature 374:546-549.
10. Lander, E. S., L. M. Linton, B. Bitten, C. Nusbaum, M. C. Zody, J. Baldwin, K. Devon, K. Dewar, M. Doyle, W. FitzHugh, R. Funke, D. Gage, K. Harris, A. Heaford, J. Howland, et al. 2001. Initial sequencing and analysis of the human genome. Nature 409:860-921.
11. Yamamoto, S., T. Yamamoto, T. Kataoka, E. Kuramoto, O. Yano, and T. Tokunaga. 1992. Unique palindromic sequences in synthetic oligonucleotides are required to induce IFN and augment IFN-mediated natural killer activity. J. Immunol. 148:4072-4076.
12. Krieg, A. M., T. Wu, R. Weeratna, S. M. Efler, L. Love-Homan, L. Yang, A. K. Yi, D. Short, and H. L. Davis. 1998. Sequence motifs in adenoviral DNA block immune activation by stimulatory CpG motifs. Proc. Natl. Acad. Sci. USA 95:12631-12636.
13. Karlin, S., W. Doerfler, and L. R. Cardon. 1994. Why is CpG suppressed in the genomes of virtually all small eukaryotic viruses but not in those of large eukaryotic viruses? J. Virol. 68:2889-2897.
14. Hartmann, G., and A. M. Krieg. 2000. Mechanism and function of a newly identified CpG DNA motif in human primary B cells. J. Immunol. 164:944-953.
15. Bauer, S., C. J. Kirschning, H. Hacker, V. Redecke, S. Hausmann, S. Akira, H. Wagner, and G. B. Lipford. 2001. Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition. Proc. Natl. Acad. Sci. USA 98:9237-9242.
16. Agrawal, S., and E. R. Kandimalla. 2002. Medicinal chemistry and therapeutic potential of CpG DNA. Trends Mol. Med. 8:114-121.
17. Hemmi, H., O. Takeuchi, T. Kawai, T. Kaisho, S. Sato, H. Sanjo, M. Matsumoto, K. Hoshino, H. Wagner, K. Takeda, and S. Akira. 2000. A Toll-like receptor recognizes bacterial DNA. Nature 408:740-745.
18. Wagner, H. 2002. Interactions between bacterial CpG-DNA and TLR9 bridge innate and adaptive immunity. Curr. Opin. Microbiol. 5:62-69.
19. Ashkar, A. A., and K. L. Rosenthal. 2002. Toll-like receptor 9, CpG DNA and innate immunity. Curr. Mol. Med. 2:545-556.
20. Broide, D. H., G. Stachnick, D. Castaneda, J. Nayar, M. Miller, J. Y. Cho. M. Roman, J. Zubeldia, T. Hayashi, E. Raz, and T. Hyashi. 2001. Systemic administration of immunostimulatory DNA sequences mediates reversible inhibition of Th2 responses in a mouse model of asthma. J. Clin. Immunol. 21:175-182.
21. Choudhury, B. K., J. S. Wild, R. Alam, D. M. Klinman. I. Boldogh, N. Dharajiya, W. J. Mileski, and S. Sur. 2002. In vivo role of p38 mitogen-activated protein kinase in mediating the anti-inflammatory effects of CpG oligodeoxynucleotide in murine asthma. J. Immunol. 169:5955-5961.
22. Sur, S., J. S. Wild, B. K. Choudhury, N. Sur, R. Alam, and D. M. Klinman. 1999. Long term prevention of allergic lung inflammation in a mouse model of asthma by CpG oligodeoxynucleotides. J. Immunol. 162:6284-6293.
23. Broide, D., J. Schwarze, H. Tighe, T. Gifford, M. D. Nguyen, S. Malek, J. Van Uden, E. Martin-Orozco, E. W. Gelfand, and E. Raz. 1998. Immunostimulatory DNA sequences inhibit IL-5, eosinophilic inflammation, and airway hyperresponsiveness in mice. J. Immunol. 161:7054-7062.
24. Kline, J. N., T. J. Waldschmidt, T. R. Businga, J. E. Lemish, J. V. Weinstock, P. S. Thorne, and A. M. Krieg. 1998. Modulation of airway inflammation by CpG oligodeoxynucleotides in a murine model of asthma. J. Immunol. 160:2555-2559.
25. Santeliz, J. V., G. Van Nest, P. Traquina, E. Larsen, and M. Wills-Karp. 2002. Amb a 1-linked CpG oligodeoxynucleotides reverse established airway hyperresponsiveness in a murine model of asthma. J. Allergy Clin. Immunol. 109:455-462.
26. Jain, V. V., K. Kitagaki, T. Businga, I. Hussain, C. George, P. O'Shaughnessy, and J. N. Kline. 2002. CpG-oligodeoxynucleotides inhibit airway remodeling in a murine model of chronic asthma. J. Allergy Clin. Immunol. 110:867-872.
27. Cho, J. Y, M. Miller, K. J. Baek, D. Castaneda, J. Nayar, M. Roman, E. Raz, and D. H. Broide. 2001. Immunostimulatory DNA sequences inhibit respiratory syncytial viral load, airway inflammation, and mucus secretion. J. Allergy Clin. Immunol. 108:697-702.
28. Broide, D., J. Y. Cho, M. Miller, J. Nayar, G. Stachnick, D. Castaneda, M. Roman, and E. Raz. 2000. Modulation of asthmatic response by immuno-stimulatory DNA sequences. Springer Semin. Immunopathol. 22:117-124.
29. Hussain, I., and J. N. Kline. 2001. CpG oligodeoxynucleotides in asthma. Curr Opin. Investig. Drugs 2:914-918.
30. Horner, A. A., and E. Raz. 2002. Immunostimulatory sequence oligodeoxy-nucleotide-based vaccination and immunomodulation: two unique but complementary strategies for the treatment of allergic diseases. J. Allergy Clin. Immunol. 110:706-712.
31. Krieg, A. M. 2002. From A to Z on CpG. Trends Immunol. 23:64-65.